Ultrapulse Carbon Dioxide Laser Treatment of Porokeratotic Eccrine Ostial and Dermal Duct Nevus

Abstract

Porokeratotic eccrine ostial and dermal duct nevus (PEODDN) is a rare, benign, cutaneous hamartoma. Approximately 45 cases of PEODDN have been reported, with little information regarding treatment. We report a patient with PEODDN treated successfully using an ultrapulse carbon dioxide laser.

Widespread presentation and spontaneous regression of porokeratotic eccrine ostial and dermal duct nevus

“…Clinical improvement has been most consistently reported with CO 2 laser. 1 , 4 , 11 , 12 , 13 Improvement has also been reported with topical tretinoin (0.5%) cream with urea (10%) 14 and topical photodynamic therapy with aminolevulinic acid. 15 The 2 infants described here had significant spontaneous improvement in clinical appearance despite widespread involvement noted at birth.…”

Porokeratotic adnexal ostial naevus: review on the entity and therapeutic approach

“…23 PAON responded to treatment with tazarotene gel, 26 dithranol short-contact treatment 17 and topical photodynamic therapy, 23 but laser treatments such as carbon dioxide laser as in our patient 8,19,20,[27][28][29] and with erbium/carbon dioxide laser 30 appear to be more efficient in most but not all patients. 31 Topical steroids and topical tretinoin seem to be mostly ineffective. As the successful treatments are the ones usually reported, it is difficult to propose a rational base for treatment or evidence-based treatment options.…”

A promising split‐lesion technique for rapid tattoo removal using a novel sequential approach of a single sitting of pulsed CO2 followed by Q‐switched Nd: YAG laser (1064 nm)

“…Overview of Lasers used in tattoo removal . *Q‐switched alexandrite laser (4 passes with an interval of 20 min between passes), ‡ used for cosmetic tattoo with multiple colors and flesh‐colored Iron oxide tattoo, † used for traumatic tattoos and tattoo allergy, ¶ QS R uby with AFR (10 600 nm)/ NAFR (1550 nm) or AFR (2940 nm) with QS Nd : YAG .…”

“…Thus, if used cautiously with the primary aim of ablating the epidermis, there is minimal dermal damage and consequentially little scarring. Our experience with this mode of therapy in various myriad disorders emboldened us to try it for tattoos. Unlike type I/II skin types, the “pigmented skin” is not an optical window, and thus, removal of the epidermis can help in targeting the dermal tattoo pigment with less beam scattering and could probably help in faster results .…”